Tag: gadolinium
ACR Committee on Drugs and Contrast Media classifies Elucirem injection a...
Guerbet has announced in a press release that based on the most recent scientific and clinical evidence, the American College of Radiology (ACR) Committee...
Guerbet announces US Food and Drug Administration approval of Elucirem
Guerbet announced that the US Food and Drug Administration (FDA), after priority review, has approved Elucirem (Gadopiclenol), a new macrocyclic gadolinium-based contrast agent (GBCA)...
Study finds no evidence that gadolinium causes neurologic harm
There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented at the...
